446 related articles for article (PubMed ID: 24696607)
1. Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.
Bennike T; Birkelund S; Stensballe A; Andersen V
World J Gastroenterol; 2014 Mar; 20(12):3231-44. PubMed ID: 24696607
[TBL] [Abstract][Full Text] [Related]
2. Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.
Wasinger VC; Yau Y; Duo X; Zeng M; Campbell B; Shin S; Luber R; Redmond D; Leong RW
Mol Cell Proteomics; 2016 Jan; 15(1):256-65. PubMed ID: 26530476
[TBL] [Abstract][Full Text] [Related]
3. Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review.
Gisbert JP; Chaparro M
J Crohns Colitis; 2019 Mar; 13(3):374-384. PubMed ID: 30307487
[TBL] [Abstract][Full Text] [Related]
4. Proteomic insights on the metabolism in inflammatory bowel disease.
Pisani LF; Moriggi M; Gelfi C; Vecchi M; Pastorelli L
World J Gastroenterol; 2020 Feb; 26(7):696-705. PubMed ID: 32116417
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease.
Vitali R; Palone F; Armuzzi A; Fulci V; Negroni A; Carissimi C; Cucchiara S; Stronati L
J Crohns Colitis; 2023 Jan; 17(1):92-102. PubMed ID: 36040453
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease.
Han NY; Kim EH; Choi J; Lee H; Hahm KB
J Dig Dis; 2012 Oct; 13(10):497-503. PubMed ID: 22988922
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip.
Chen CS; Sullivan S; Anderson T; Tan AC; Alex PJ; Brant SR; Cuffari C; Bayless TM; Talor MV; Burek CL; Wang H; Li R; Datta LW; Wu Y; Winslow RL; Zhu H; Li X
Mol Cell Proteomics; 2009 Aug; 8(8):1765-76. PubMed ID: 19357087
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC.
Starr AE; Deeke SA; Ning Z; Chiang CK; Zhang X; Mottawea W; Singleton R; Benchimol EI; Wen M; Mack DR; Stintzi A; Figeys D
Gut; 2017 Sep; 66(9):1573-1583. PubMed ID: 27216938
[TBL] [Abstract][Full Text] [Related]
9. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
[TBL] [Abstract][Full Text] [Related]
10. Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science.
Sorrentino D; Nguyen VQ; Chitnavis MV
Cells; 2019 Jun; 8(6):. PubMed ID: 31174359
[TBL] [Abstract][Full Text] [Related]
11. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
12. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
Williams AD; Korolkova OY; Sakwe AM; Geiger TM; James SD; Muldoon RL; Herline AJ; Goodwin JS; Izban MG; Washington MK; Smoot DT; Ballard BR; Gazouli M; M'Koma AE
PLoS One; 2017; 12(8):e0179710. PubMed ID: 28817680
[TBL] [Abstract][Full Text] [Related]
13. A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review.
Fabian O; Bajer L; Drastich P; Harant K; Sticova E; Daskova N; Modos I; Tichanek F; Cahova M
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298338
[TBL] [Abstract][Full Text] [Related]
14. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
Torres J; Petralia F; Sato T; Wang P; Telesco SE; Choung RS; Strauss R; Li XJ; Laird RM; Gutierrez RL; Porter CK; Plevy S; Princen F; Murray JA; Riddle MS; Colombel JF
Gastroenterology; 2020 Jul; 159(1):96-104. PubMed ID: 32165208
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
Yang Z; Clark N; Park KT
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease.
Di Narzo AF; Brodmerkel C; Telesco SE; Argmann C; Peters LA; Li K; Kidd B; Dudley J; Cho J; Schadt EE; Kasarskis A; Dobrin R; Hao K
J Crohns Colitis; 2019 Mar; 13(4):462-471. PubMed ID: 30445421
[TBL] [Abstract][Full Text] [Related]
17. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children.
Filimoniuk A; Blachnio-Zabielska A; Imierska M; Lebensztejn DM; Daniluk U
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708181
[TBL] [Abstract][Full Text] [Related]
19. Proteomic and lipidomic biomarkers in the diagnosis and progression of inflammatory bowel disease - a review.
Cecerska-Heryć E; Ronkowski B; Heryć R; Serwin N; Grygorcewicz B; Roszak M; Galant K; Dołęgowska B
Proteomics Clin Appl; 2023 Jan; 17(1):e2200003. PubMed ID: 36043901
[TBL] [Abstract][Full Text] [Related]
20. Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia.
Neubauer K; Bednarz-Misa I; Walecka-Zacharska E; Wierzbicki J; Agrawal A; Gamian A; Krzystek-Korpacka M
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]